{"component": "definition", "props": {"groups": [{"snippet_links": [{"key": "joint-planning-committee", "type": "definition", "offset": [6, 30]}], "snippet": "means Joint Planning Committee.", "size": 38, "samples": [{"hash": "a5V8lDi9Qbm", "uri": "/contracts/a5V8lDi9Qbm#jpc", "label": "Joint Operating Agreement", "score": 34.5034332275, "published": true}, {"hash": "2W3oVlHOMAQ", "uri": "/contracts/2W3oVlHOMAQ#jpc", "label": "Joint Reliability Coordination Agreement", "score": 34.1562805176, "published": true}, {"hash": "4Z4BukjDQvJ", "uri": "/contracts/4Z4BukjDQvJ#jpc", "label": "Joint Operating Agreement", "score": 33.5661621094, "published": true}], "hash": "17e1cec11c3de8ea656784d9f21bf569", "id": 1}, {"snippet_links": [{"key": "joint-planning-committee", "type": "definition", "offset": [10, 34]}], "snippet": "means the Joint Planning Committee.", "size": 22, "samples": [{"hash": "8pWrdIfYdVW", "uri": "/contracts/8pWrdIfYdVW#jpc", "label": "Joint Operating Agreement", "score": 33.6822242737, "published": true}, {"hash": "jxU95S1ogRJ", "uri": "/contracts/jxU95S1ogRJ#jpc", "label": "Joint Operating Agreement", "score": 27.5420951843, "published": true}, {"hash": "alxIKE7khVi", "uri": "/contracts/alxIKE7khVi#jpc", "label": "Joint Operating Agreement", "score": 27.5338802338, "published": true}], "hash": "877a13abf07a1bb408c8e3f3ea9fd213", "id": 2}, {"snippet_links": [{"key": "section-91", "type": "clause", "offset": [29, 40]}], "snippet": "has the meaning set forth in Section 9.1.", "size": 18, "samples": [{"hash": "2o0fQJAE3uV", "uri": "/contracts/2o0fQJAE3uV#jpc", "label": "Development, Commercialization and License Agreement", "score": 31.3408622742, "published": true}, {"hash": "lb5hGUyOgjH", "uri": "/contracts/lb5hGUyOgjH#jpc", "label": "License Agreement (Ionis Pharmaceuticals Inc)", "score": 29.3449687958, "published": true}, {"hash": "OJp8iwZMz4", "uri": "/contracts/OJp8iwZMz4#jpc", "label": "License Agreement (Akcea Therapeutics, Inc.)", "score": 29.1998634338, "published": true}], "hash": "9e2f585a8295c1fe153723c4384c5bd4", "id": 3}, {"snippet_links": [{"key": "section-31", "type": "definition", "offset": [29, 40]}], "snippet": "has the meaning set forth in Section 3.1.", "size": 17, "samples": [{"hash": "c6HFj3QbN4c", "uri": "/contracts/c6HFj3QbN4c#jpc", "label": "Services and Collaboration Agreement (Moderna, Inc.)", "score": 29.8542098999, "published": true}, {"hash": "hgl3pVkk0ML", "uri": "/contracts/hgl3pVkk0ML#jpc", "label": "Services and Collaboration Agreement (Moderna, Inc.)", "score": 29.659822464, "published": true}, {"hash": "47nra7R4rKw", "uri": "/contracts/47nra7R4rKw#jpc", "label": "License Agreement (Nektar Therapeutics)", "score": 28.8521556854, "published": true}], "hash": "3d19223e249d2e344053d0014b14d616", "id": 4}, {"snippet_links": [{"key": "section-24", "type": "definition", "offset": [29, 40]}], "snippet": "has the meaning set forth in Section 2.4.", "size": 15, "samples": [{"hash": "bSQ5oKQ0LWf", "uri": "/contracts/bSQ5oKQ0LWf#jpc", "label": "Research and Collaboration Agreement (ProQR Therapeutics N.V.)", "score": 33.9746742249, "published": true}, {"hash": "b8Mb6HjAPBB", "uri": "/contracts/b8Mb6HjAPBB#jpc", "label": "Research and Collaboration Agreement (ProQR Therapeutics N.V.)", "score": 32.6851463318, "published": true}, {"hash": "l4TM5CRSZdI", "uri": "/contracts/l4TM5CRSZdI#jpc", "label": "Inhaled Collaboration and Option Agreement (Liquidia Technologies Inc)", "score": 27.5284061432, "published": true}], "hash": "9cee8c98c8f7a77064508ab208b6ca28", "id": 5}, {"snippet_links": [], "snippet": "has the meaning set forth in Section 7.1.3(a).", "size": 14, "samples": [{"hash": "9QxSD4AkxY4", "uri": "/contracts/9QxSD4AkxY4#jpc", "label": "HTT Research, Development, Option and License Agreement (Ionis Pharmaceuticals Inc)", "score": 34.3333320618, "published": true}, {"hash": "7CoFyFfYwto", "uri": "/contracts/7CoFyFfYwto#jpc", "label": "Neurology Drug Discovery and Development Collaboration, Option and License Agreement (Ionis Pharmaceuticals Inc)", "score": 32.8384666443, "published": true}, {"hash": "ifHZPNK2QAv", "uri": "/contracts/ifHZPNK2QAv#jpc", "label": "Research Collaboration, Option and License Agreement (Ionis Pharmaceuticals Inc)", "score": 32.1485290527, "published": true}], "hash": "ab8a744fe3e67399ae8064460e4a2729", "id": 6}, {"snippet_links": [], "snippet": "means the Japanese Paralympic Committee.", "size": 9, "samples": [{"hash": "5qn1HcslxZ6", "uri": "https://travel.teamgblive.com/media/4765/team-gb-tokyo-2020-21-package-terms-conditions-february-2021.pdf", "label": "travel.teamgblive.com", "score": 10.5386724472, "published": false}, {"hash": "j77obj4H03H", "uri": "https://travel.teamgblive.com/media/4547/team-gb-tokyo-2020-package-terms-november-2020.pdf", "label": "travel.teamgblive.com", "score": 10.4140996933, "published": false}, {"hash": "3E4A3B3NyLK", "uri": "https://travel.teamgblive.com/media/4395/team-gb-tokyo-2020-package-terms-september-2020.pdf", "label": "travel.teamgblive.com", "score": 10.3511295319, "published": false}], "hash": "e2c7aa6c5aa27cad4b73b0061466e77e", "id": 7}, {"snippet_links": [], "snippet": "has the meaning set forth in Section 2.1(a).", "size": 7, "samples": [{"hash": "dv1QK7B0aWi", "uri": "/contracts/dv1QK7B0aWi#jpc", "label": "Collaboration and License Agreement (Facet Biotech Corp)", "score": 21.2847366333, "published": true}, {"hash": "dFAuIortDj4", "uri": "/contracts/dFAuIortDj4#jpc", "label": "Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)", "score": 21.2108154297, "published": true}, {"hash": "fXtvZWd168N", "uri": "/contracts/fXtvZWd168N#jpc", "label": "Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)", "score": 21.0, "published": true}], "hash": "d35e167b65d2195414541e0496edeec8", "id": 8}, {"snippet_links": [{"key": "the-committee", "type": "clause", "offset": [6, 19]}, {"key": "by-the-parties", "type": "clause", "offset": [27, 41]}, {"key": "section-32", "type": "clause", "offset": [58, 69]}], "snippet": "means the committee formed by the Parties as described in Section 3.2.", "size": 5, "samples": [{"hash": "3hXwzp8nQuV", "uri": "/contracts/3hXwzp8nQuV#jpc", "label": "Development and License Agreement (Concert Pharmaceuticals, Inc.)", "score": 25.0903491974, "published": true}, {"hash": "lPCRK2GEqSP", "uri": "/contracts/lPCRK2GEqSP#jpc", "label": "Development and License Agreement (Concert Pharmaceuticals, Inc.)", "score": 24.8466796875, "published": true}], "hash": "bde71bdb58ada4dac59ee1e752081e9a", "id": 9}, {"snippet_links": [{"key": "section-501", "type": "clause", "offset": [36, 48]}], "snippet": "shall have the meaning set forth in Section 5.01.", "size": 5, "samples": [{"hash": "9D6YX2xlDWp", "uri": "/contracts/9D6YX2xlDWp#jpc", "label": "License Agreement (Alliance Pharmaceutical Corp)", "score": 18.0, "published": true}, {"hash": "1BFTFcGAHe3", "uri": "/contracts/1BFTFcGAHe3#jpc", "label": "License Agreement (Alliance Pharmaceutical Corp)", "score": 18.0, "published": true}], "hash": "7f3a9091f1c0bf6d09659b3d748bf0a6", "id": 10}], "next_curs": "ClASSmoVc35sYXdpbnNpZGVyY29udHJhY3RzciwLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIManBjIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"snippet": "means Joint Planning Committee.", "title": "JPC", "size": 216, "id": "jpc", "examples": ["For the avoidance of doubt, notwithstanding any agreed meeting schedule of the <strong>JPC</strong>, the Parties shall communicate as necessary in order to ensure the effective management of the Parties\u2019 intellectual property rights set forth in Article 10.", "The Alliance Managers shall have the right to attend all meetings of the JSC, JDC, JMC, <strong>JPC</strong> and all other Committees (if any) as non-voting members, and shall bring matters to the attention of the relevant Committee if the Alliance Manager reasonably believes that such matter warrants such attention.", "At the request of either Party, the Parties will enter into a common interest agreement with respect to information exchanged, disclosed and discussed by the Parties at the <strong>JPC</strong>.", "The <strong>JPC</strong> shall serve as the primary contact between the Parties regarding the exchange of information with respect to intellectual property matters arising under this Agreement.", "All decisions within the decision-making authority of the <strong>JPC</strong> shall be made by [***].", "Within [***], the Parties shall establish a joint patent committee (the \u201c<strong>JPC</strong>\u201d), composed of [***], each of whom will have appropriate experience prosecuting patents and the appropriate experience and expertise to perform its responsibilities on the <strong>JPC</strong>.", "The Parties will, through the <strong>JPC</strong>, discuss and agree upon an allocation of responsibility between the Parties for the filing, prosecution and maintenance of Joint Patents, as set forth in Section 3.5(a).", "The Party selected by the <strong>JPC</strong> to control the filing, prosecution and maintenance of a given Joint Patent shall keep the other Party (through the <strong>JPC</strong>) [***] informed of the status of such Joint Patent and shall [***] provide such other Party (through the <strong>JPC</strong>) with material correspondence received from any patent authorities in connection therewith.", "Without limiting the foregoing and to the extent consistent with the terms of Article 10, the <strong>JPC</strong> shall: (i) [***] (ii) [***] (iii) [***] (iv) [***] (v) [***] (vi) [***] (vii) [***] (viii) [***] and (ix) [***].", "Each Committee shall hold meetings at such times as the Parties mutually agree, but in no event shall such meetings be held less frequently than (i) for the JSC, once every [***]; (ii) for the JDC, once every [***]; (iii) for the JMC, [***] and (iv) for the <strong>JPC</strong>, [***]."], "related": [["jdc", "JDC", "JDC"], ["jsc", "JSC", "JSC"], ["jrc", "JRC", "JRC"], ["jcc", "JCC", "JCC"], ["jmc", "JMC", "JMC"]], "related_snippets": [], "updated": "2026-03-14T06:33:37+00:00"}, "json": true, "cursor": ""}}